1. Home
  2. DSGX vs PTCT Comparison

DSGX vs PTCT Comparison

Compare DSGX & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Descartes Systems Group Inc. (The)

DSGX

Descartes Systems Group Inc. (The)

HOLD

Current Price

$71.26

Market Cap

6.2B

Sector

Technology

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$69.32

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSGX
PTCT
Founded
1981
1998
Country
Canada
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
5.7B
IPO Year
1999
2006

Fundamental Metrics

Financial Performance
Metric
DSGX
PTCT
Price
$71.26
$69.32
Analyst Decision
Buy
Buy
Analyst Count
9
17
Target Price
$105.22
$80.65
AVG Volume (30 Days)
554.2K
733.3K
Earning Date
06-03-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
264.48
EPS
N/A
7.78
Revenue
N/A
$264,734,000.00
Revenue This Year
$12.05
N/A
Revenue Next Year
N/A
$17.70
P/E Ratio
$37.05
$8.75
Revenue Growth
N/A
36.19
52 Week Low
$62.56
$35.95
52 Week High
$117.35
$87.50

Technical Indicators

Market Signals
Indicator
DSGX
PTCT
Relative Strength Index (RSI) 49.29 48.31
Support Level $68.82 $64.00
Resistance Level $74.91 $69.23
Average True Range (ATR) 2.79 2.38
MACD 0.15 -0.33
Stochastic Oscillator 54.92 25.12

Price Performance

Historical Comparison
DSGX
PTCT

About DSGX Descartes Systems Group Inc. (The)

Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: